| HOME >> BIOLOGY >> TECHNOLOGY |
Safe Harbor Statement Under the Private Securities Litigation Reform
Act of 1995: Certain statements in this press release and oral statements
made by the Company, constitute forward-looking statements for purposes of
the safe harbor provisions under The Private Securities Litigation Reform
Act of 1995. These statements include, without limitation, statements
regarding our ability to prepare the company for growth, the Company's
planned capacity expansion in 2008 and predictions and guidance relating to
the Company's future financial performance. We have based these
forward-looking statements largely on our current expectations and
projections about future events and financial trends that we believe may
affect our financial condition, results of operations, business strategy
and financial needs but they involve risks and uncertainties that could
cause actual results to differ materially from those in the forward-looking
statements, which may include, but are not limited to, such factors as
unanticipated changes in product demand especially in the pharmaceutical
industry, pricing and demand trends for the Company's products, changes to
government regulations, risk associated with operation of the Company's new
facilities, risk associated with large scale implementation of the
company's business plan, the ability to attract new customers, ability to
increase its product's applications, cost of raw materials, downturns in
the Chinese economy, and other information detailed from time to time in
the Company's filings and future filings with the United States Securities
and Exchange Commission. Investors are urged to consider these factors
carefully in evaluating the forward-looking statements herein and are
cautioned not to place undue reliance on such forward-looking statements,
which are qualified in their entirety by this cautionary statement. The
forward-looking statements made herein speak only as of the date of this
press release and the Company undert
'/>"/>
| SOURCE Shengtai Pharmaceutical, Inc. Copyright©2008 PR Newswire. All rights reserved |